Antimonite Belladonna
- Product NDC
- 48951-1037
- 11-digit product format
- 489511037
- Labeler code
- 48951
- Product ID
- 48951-1037_6983c4f2-0167-ba15-e053-2991aa0a3625
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Antimonite Belladonna
- Dosage form
- POWDER
- Route
- ORAL
- Labeler
- Uriel Pharmacy Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2009-09-01
- Marketing end
- 0000-00-00
- Substance
- ANTIMONY TRISULFIDE; ATROPA BELLADONNA; MATRICARIA RECUTITA; BISMUTH SUBNITRATE
- Active strength
- 3 [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 48951-1037 | I | Inactivated by FDA | 2026-10-15 | ||
| excluded package | package | 48951-1037 | 48951-1037-4 | I | Inactivated by FDA | 2026-10-15 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 0be8e4ae-4d57-49f3-b3a9-e4728b4e8d15 | Product name | 1 | 20240313 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 48951-1037-4 | Antimonite Belladonna | 50 g in 1 BOTTLE, GLASS | POWDER | 50 | 5 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ANTIMONY TRISULFIDE | ACTIVE INGREDIENT | F79059A38U | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| ATROPA BELLADONNA | ACTIVE INGREDIENT | WQZ3G9PF0H | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| BISMUTH SUBNITRATE | ACTIVE INGREDIENT | H19J064BA5 | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| MATRICARIA RECUTITA | ACTIVE INGREDIENT | G0R4UBI2ZZ | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| ANTIMONY TRISULFIDE | ACTIVE MOIETY | F79059A38U | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| ATROPA BELLADONNA | ACTIVE MOIETY | WQZ3G9PF0H | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| BISMUTH CATION | ACTIVE MOIETY | ZS9CD1I8YE | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| MATRICARIA RECUTITA | ACTIVE MOIETY | G0R4UBI2ZZ | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 48951-1037 | ANTIMONITE BELLADONNA POWDER [URIEL PHARMACY INC.] | 5 | Legacy NDC, 1 package rows | 20240113_0bc61339-130a-459b-9c61-2a12b5572347.zip |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 48951-1037-4 | 48951103704 | 50 g in 1 BOTTLE, GLASS (48951-1037-4) | 50 g | 2009-09-01 | 0000-00-00 | No | No | Current |